Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Syncom Formulations India Ltd (SYFI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.96 -0.02    -0.14%
05:59:59 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE312C01025 
S/N:  SYNCOMF
  • Volume: 425,081
  • Bid/Ask: 13.95 / 14.04
  • Day's Range: 13.76 - 14.17
Syncom Formulations India 13.96 -0.02 -0.14%

Syncom Formulations India Ltd Company Profile

 
Get an in-depth profile of Syncom Formulations India Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

555

Equity Type

ORD

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It also offers anemia tablet and syrup, lycopene, minerals and vitamins capsules, products for eradication of vaginal pathogens, capsules for the treatment of menopause, herbal uterine tonic, syrup for the treatment lactation insufficiency, cough suppressants, liver tonic, medicine for burning urination, and nutritional supplements. In addition, the company engages in the trading of commodities and renting of properties. Further, it exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Contact Information

Address Syncom House 207, Saket Nagar
Near Saket Club Indore, 452018
India
Phone 91 73 1270 0458
Fax -

Top Executives

Name Age Since Title
Vijay Shankarlal Bankda 66 1999 MD and Executive & Non Independent Director
Rinki Ankit Bankda 37 2014 Whole Time Director
Kedarmal Shankarlal Bankda 72 1992 Executive Chairman
Ruchi Jindal 34 2022 Additional Non-Executive Independent Woman Director
Vinod Kumar Kabra 72 2007 Independent Non-Executive Director
Ritesh Kumar Lunkad 49 2023 Additional Non-Executive Independent Director
Ankit Jain 37 2023 Additional Non-Executive Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SYFI Comments

Write your thoughts about Syncom Formulations India Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
ABC ABCD
ABC ABCD Mar 27, 2024 4:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy for long term
Keep Gaming
Keep Gaming Jan 03, 2023 1:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
all Pharma up but this garbage stuck in the red
Keep Gaming
Keep Gaming Dec 29, 2022 11:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
m c kab bhagega bsd k
Pratik Paul
Pratik Paul Apr 13, 2022 6:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy syncom formulation target🚀 84+
ganesh moharil
ganesh moharil Jan 05, 2022 11:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
congratulations all-time high achived .... keep invested .... best yet to come
AJAY BAGHEL
AJAY BAGHEL Dec 29, 2021 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I have hold still 10000 shears from 0.60 pesa should I wait or exit
Jasim Surve
Jasim Surve Dec 29, 2021 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
operator driven share.
vaidik Tiwari
vaidik Tiwari Dec 29, 2021 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wait
Manish Chavda
Manish Chavda Dec 09, 2021 11:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today last day for ASM .....Monday it will removed from ASM stage....also circuit filter 20% from 10%.....enjoy investment
Manish Chavda
Manish Chavda Dec 03, 2021 6:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shakti Thakkar is totally fraud man .....please stay away from his comments on Money control....
Manish Chavda
Manish Chavda Dec 03, 2021 6:55AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Saktida is totaly fraud man ..... don't trust on him ....stay away from his comments on Money control
Manish Chavda
Manish Chavda Dec 03, 2021 6:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Syncom future is bright.....so long term investor will enter in up coming days...stay invest
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email